AXA Framlington Health Fund

Select share classes

AXA Framlington Health Fund Z Acc

Category Sector Equity Healthcare

star-filledstar-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

413.30p

arrow-up0.60p (+0.15%)

Fund Code

FMHEA

B6WZJX0

GB00B6WZJX05

Prices updated as at 28 Mar 2025
|
Prices in GBX

Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Portfolio as of 31/01/2025

Asset allocation

Created with Highcharts 7.2.298.89% Stocks- Bonds1.11% Cash- Other- Not classified
Show long & short position

Geographical breakdown

Continent or country allocation (%)

Created with Highcharts 7.2.25.615.6111.2311.2313.5113.5169.6569.65United KingdomEurozoneEurope - ex EuroUnited States

Market classification (%)

Created with Highcharts 7.2.2100100EmergingDeveloped

Stock style

Large growth

26.96%

% Weight
Value
Core
Growth
Large

24

18

27

Medium

0

12

10

Small

2

2

5

Valuation

AXA Framlington Health Fund Z Acc
Sector Equity Healthcare

19.67

19.67
19.89

1.90

1.90
1.94

4.14

4.14
4.38

17.67

17.67
17.13

Growth rate

AXA Framlington Health Fund Z Acc
Sector Equity Healthcare

11.50%

11.50%
10.83%

1.25%

1.25%
1.33%

-0.08%

-0.08%
1.29%

Top 10 holdings

Security nameSectorCountry% of assets
1Eli Lilly and Co-United States8.67
2Merck & Co Inc-United States4.98
3Thermo Fisher Scientific Inc-United States4.98
4UnitedHealth Group Inc-United States4.87
5Novo Nordisk AS Class B-Denmark4.83
6AstraZeneca PLC-United Kingdom4.53
7Becton Dickinson & Co-United States4.37
8Intuitive Surgical Inc-United States3.70
9DexCom Inc-United States3.43
10Boston Scientific Corp-United States2.79
Assets in top 10 holdings %

47.15%

Total no. of equity holdings

47.00

Total no. of bond holdings

-

Stock sectors

AXA Framlington Health Fund Z Acc
Sector Equity Healthcare

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

1.20%

Comm services

-
-

Energy

-
-

Industrials

1.20%
-

Technology

-
-

98.80%

Con defensive

-
-

Healthcare

98.80%
-

Utilities

-
-


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.